Claritas Pharmaceuticals Inc V.CLAS.H

Weird, first they blame the TSX for all the BS, now they are

[Dude51]

blaming CMAX for all there338718338718* woes. Man what a bunch shysters, imo.

Claritas is focused on completing the phase 1 study as quickly as possible. Due to the inability of CMAX Clinical Research to provide an assurance that the phase 1 study will be completed during Q1 2022, Claritas has terminated its agreement with CMAX, and has entered into a clinical trial research agreement with Scientia Clinical Research, a state-of-the-art clinical trials facility with a focus on first-in-human and first-in-patient clinical studies located in Sydney, Australia. Scientia possesses world-class clinical trial expertise and conducts a wide range of clinical trials, with a focus on early stage clinical research. Scientia will use best efforts to complete the phase 1 study during Q1 2022.

[PTBailey]

From what I gather they are both connected. A long approval process at TSX for approal of financies resulted in missing the date for phase 1. If the approval process had taken two weeks instead of two months we would have had the money to pay CMAX. When we missed the orginal schedule time slot CMAX couldn't fit us in again until April which is whey they went looking somewhere else. Anyone

[bobbybittman]

so the market has reacted by smashing the share price but we should recover by next february or so